BRD2 and renal pelvis/ureter urothelial carcinoma: In this cohort, previous, synchronous or metachronous bilateral UTUC diseases were identified in 18 patients, of whom 14 (78%) from AT group, 3 (17%) from NAT group, and 1 (6%) from WT group.